These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28235211)

  • 61. All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study.
    Callaghan RC; Cunningham JK; Verdichevski M; Sykes J; Jaffer SR; Kish SJ
    Drug Alcohol Depend; 2012 Oct; 125(3):290-4. PubMed ID: 22503689
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Associations Between Family History of Substance Use, Childhood Trauma, and Age of First Drug Use in Persons With Methamphetamine Dependence.
    Svingen L; Dykstra RE; Simpson JL; Jaffe AE; Bevins RA; Carlo G; DiLillo D; Grant KM
    J Addict Med; 2016; 10(4):269-73. PubMed ID: 27427901
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exploring the prevalence and correlates of methamphetamine use: findings from Sacramento's ADAM program.
    Yacoubian GS; Peters RJ
    J Drug Educ; 2004; 34(3):281-94. PubMed ID: 15648888
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The clinical characteristics of adolescents reporting methamphetamine as their primary drug of choice: an examination of youth admitted to inpatient substance-abuse treatment in northern British Columbia, Canada, 2001-2005.
    Callaghan RC; Brands B; Taylor L; Lentz T
    J Adolesc Health; 2007 Mar; 40(3):286-9. PubMed ID: 17321434
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An investigation of relations between crystal methamphetamine use and posttraumatic stress disorder.
    Smith RC; Blumenthal H; Badour C; Feldner MT
    Addict Behav; 2010 Jun; 35(6):625-7. PubMed ID: 20153121
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of methamphetamine abuse beyond individual users.
    Watanabe-Galloway S; Ryan S; Hansen K; Hullsiek B; Muli V; Malone AC
    J Psychoactive Drugs; 2009 Sep; 41(3):241-8. PubMed ID: 19999677
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Stimulant dependence].
    Kishimoto H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):505-6. PubMed ID: 14626171
    [No Abstract]   [Full Text] [Related]  

  • 68. Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial.
    Rezaei F; Ghaderi E; Mardani R; Hamidi S; Hassanzadeh K
    Fundam Clin Pharmacol; 2016 Jun; 30(3):282-9. PubMed ID: 26751259
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Methamphetamine and HIV.
    HRSA Careaction; 2009 Jun; ():1-8. PubMed ID: 19731419
    [No Abstract]   [Full Text] [Related]  

  • 70. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
    Obert JL; Brown AH; Zweben J; Christian D; Delmhorst J; Minsky S; Morrisey P; Vandersloot D; Weiner A
    J Subst Abuse Treat; 2005 Apr; 28(3):231-7. PubMed ID: 15857723
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An exploratory study on association between family relationship and relapse among methamphetamine users in Compulsory Treatment System of Khon Kaen and Yasothon Provinces.
    Rodseeda P; Ratanasiri A; Kanato M; Pinitsoontorn S; Chiawiriyabunya I
    J Med Assoc Thai; 2010 Mar; 93 Suppl 3():S1-5. PubMed ID: 21302405
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
    McKetin R; Kelly E
    Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Epidemiology and public health Consequences of methamphetamine use in California's Central Valley.
    Gibson DR; Leamon MH; Flynn N
    J Psychoactive Drugs; 2002; 34(3):313-9. PubMed ID: 12422943
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methamphetamine in three small Midwestern cities: evidence of a moral panic.
    Weidner RR
    J Psychoactive Drugs; 2009 Sep; 41(3):227-39. PubMed ID: 19999676
    [TBL] [Abstract][Full Text] [Related]  

  • 75. California Substance Abuse Research Consortium, September 2005: update on recent methamphetamine trends in four California regions.
    Rutkowski BA
    J Psychoactive Drugs; 2006 Nov; Suppl 3():369-75. PubMed ID: 17357528
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Misuse of methamphetamine and prescription stimulants among youths and young adults in the community.
    Wu LT; Pilowsky DJ; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):195-205. PubMed ID: 17257780
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identifying methamphetamine users at risk for major depressive disorder: findings from the methamphetamine treatment project at three-year follow-up.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    Am J Addict; 2008; 17(2):99-102. PubMed ID: 18393051
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current and Emerging Treatments for Methamphetamine Use Disorder.
    Moszczynska A
    Curr Neuropharmacol; 2021; 19(12):2077-2091. PubMed ID: 34344291
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Meth mouth: methamphetamine and oral health.
    Padilla R; Ritter AV
    J Esthet Restor Dent; 2008; 20(2):148-9. PubMed ID: 18380848
    [No Abstract]   [Full Text] [Related]  

  • 80. Experiences of Health Professionals Caring for People Presenting to the Emergency Department After Taking Crystal Methamphetamine ("ICE").
    Cleary M; Jackson D; Woods C; Kornhaber R; Sayers J; Usher K
    Issues Ment Health Nurs; 2017 Jan; 38(1):33-41. PubMed ID: 27936336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.